10-K Decoder · All companies

Beam Therapeutics Inc.

BEAM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$140M$63.5M+120%
Operating income−$384M−$416M+7.7%
Net income−$80.0M−$377M+78.8%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026

$Q3 2026Year earlierChange
Revenue$300K$9.70M−96.9%
Operating income−$141M−$127M−11.4%
Net income−$134M−$113M−19.4%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Beam Therapeutics's revenue in FY2025?
$140M in FY2025 (Fiscal year ended Dec 31, 2025), +120% vs $63.5M a year earlier, per its 10-K filed Feb 2026.
Was Beam Therapeutics profitable in FY2025?
No: net income was −$80.0M and operating income −$384M in FY2025.
What was Beam Therapeutics's revenue in Q3 2026?
$300K (−96.9% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.